SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63388 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60993Today’s story about SAVA is actually not news. It is yet another repackaging ofjargonweary27/27/2022
60992From my perspective, the SAVA news is close to a nothing burger. The trials wilallatwwk-7/27/2022
60991U shoulda bought at 14.5 this AM, it's back up to 18 nowEMU2-7/27/2022
60990Something from STAT (Adam Feuerstein's rag) that is actually constructive. Tghettogoulash37/27/2022
60989Well, good for him for saying something and showing some spine; the last time heFitzhughlaw27/27/2022
60988I’m with you on the dividend stocks, my only non dividend stock is AUPH and I doidahoranch117/27/2022
60987There is nothing new in that article. "The sources did not provide details ghettogoulash-7/27/2022
60986Latest statement for SAVA: Cassava Sciences Responds to Media Reports July 27, Davidoff17/27/2022
60985If it quacks like a duck and looks like a duck, sometimes it's a duck!! Duhgalt17/27/2022
60984In regards to SAVA: I have been through this before and take solace that you reluckydog8817/27/2022
60983Wow. Meant to buy yesterday and forgot to place order - an often overlooked benesysiphus17/27/2022
60982Very bad news for SAVA. Between this and CTMX, I'm taking a shellacking thisdrtom1234-7/27/2022
60981Probably trying to get AUPH to settle out of court. "How­ev­er, chandler27-7/27/2022
60980AT THE PTAB BLOG 10-Year Anniversary of the AIA at the PTAB?Not Your Grandparendorightbythem-7/26/2022
60979Sun pharmaceuticals sells generics. I would speculate that if they would like toOlecranon17/26/2022
60978Stupid question for ya: Why is SUN challenging this? What do they in particulaplhky3465-7/26/2022
60977Surprised, no comment on Auph v. Sun patent dispute. Have to wait until July, 20dorightbythem-7/26/2022
60976"...resulting in me being lucky..." Hey, it worked once! If you can jerickerickson-7/25/2022
60975I was not a fan of the Goldenbergs and I have not been impressed with Barbier, ejargonweary17/25/2022
60974another AD article that casually refers to Simufilam, although with a glaring erscorman137/25/2022
60973I take some comfort in SAVA's financials in the midst of all the FUD. On a verickerickson27/24/2022
60972Yep. All true. And yet if Simufilam’s efficacy and safety are confirmed in the jargonweary-7/24/2022
60971Thanks, jw. Despite, the fact that the allegations appear to be mere handwaving,Olecranon27/24/2022
60970Yes, this article contains no new information or allegations regarding SAVA. Thjargonweary67/22/2022
60969Same old images, more or less the same old debate, but a new investigator, and pOlecranon-7/22/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News